2019, Number 11
Screening and treatment of precancerous lesions for cervical cancer prevention
Language: Spanish
References: 19
Page: 300
PDF size: 139.78 Kb.
ABSTRACT
Worldwide, cervical cancer is the third most common cancer among women, the risk factor is Human papillomavirus (HPV) but it is not a sufficient cause for the development of cervical cancer, Screening is performed using cervical cytology, a important tool for early diagnosis and effective treatment, according to studies this screening is recommended for women from the age of 21 years regardless of the onset sexual intercourse age, if the patient has a normal cytology it is recommended Screening every 3 years, otherwise monitoring will depend on the cytology´s result and complementary tests.REFERENCES
Nathalie Broutet; Jean-Marie Dangou; Ibtihal Fadhil; Gunta Lazdane; Silvana Lucian ; Arvind Mathur ; Amolo Okero; Somchai Peerapakorn; Andreas Ullrich; Cherian Varghese et al. Directrices de la OPS/OMS sobre tamizaje y tratamiento de las lesiones precancerosas para la prevención del cáncer cervicouterino [Internet]. Washington, DC: OPS, 2014. [revised 2014; cited 2019 Mar 29]. Available from: https://apps.who.int/iris/bitstream/handle/10665/105132/9789275318331_spa.pdf?sequence=1
Edna Yolany Batres; Francis Rafael Contreras; Sandra Maribel Pinel; Silvia Yolanda Nazar; Glady Paz Díaz; Dr. Billy Rolando González. Protocolo para el tamizaje y tratamiento de lesiones premalignas para la prevención del cáncer cérvicouterino[Internet]. Honduras, 2015. [revised 2015; cited 2015 Nov 19]. Available from: https://www.iccpportal.org/sites/default/files/resources/Cervical%20Cancer%20guidelines%20Honduras% 20IMPRESION%20Texto%20Protocolo.pdf
American Cancer Society. Cancer Facts & Figures. Atlanta: American Cancer Society; [Internet] NW, Atlanta,2019 [revised 2019; cited 2019 Feb].Available from: https://www.cancer.org/content/dam/cancerorg/ research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2019/cancer-facts-and-figures- 2019.pdf
Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, Garcia FAR, Moriarty AT, Waxman AG, Wilbur DC, Wentzensen N, Downs LS, Spitzer M, Moscicki A, Franco EL, Stoler MH, Schiffman M, Castle PE, Myers ER, . American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA: A Cancer Journal for Clinicians. 2012 03 14;62(3):147- 172. https://doi.org/10.3322/caac.21139
Concepción J, Álvarez E, Reyes O. Tratamiento observacional vs. ablativo de las lesiones intraepiteliales escamosas de bajo grado. Estudio de cohorte pareado retrospectivo. Enero 2010-Enero 2014. Clínica e Investigación en Ginecología y Obstetricia. 2017 01;44(1):16- 20. https://doi.org/10.1016/j.gine.2015.05.006
Orozco, L.; Tristán, M.; Beitia, A.; Vreugdenhil, M.T.; Andrino, R.; Agüero, C.; García, M.E.; Umaña, A.; Guerrero, S.; Cruz, J.; Guidos, M.; Cárcamo, W.; Rodríguez H. Guía de práctica clínica para el manejo de lesiones premalignas del cuello del útero [Internet]. 2017 [Consultado 22 Setp 2019]. Disponible en: http://www.fecasog.com/sites/default/files/2017-04/Manejo-de-lesiones-premalignas-de-cuello-delutero. pdf
Cibula D, Pötter R, Planchamp F, Avall-Lundqvist E, Fischerova D, Haie Meder C, Köhler C, Landoni F, Lax S, Lindegaard JC, Mahantshetty U, Mathevet P, McCluggage WG, McCormack M, Naik R, Nout R, Pignata S, Ponce J, Querleu D, Raspagliesi F, Rodolakis A, Tamussino K, Wimberger P, Raspollini MR. The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer. International Journal of Gynecologic Cancer. 2018 05;28(4):641- 655. https://doi.org/10.1097/igc.0000000000001216